Hernández, José L.
Baldeón, Cristina
López-Sundh, Ana E.
Ocejo-Vinyals, J. Gonzalo
Blanco, Ricardo
González-López, Marcos A. https://orcid.org/0000-0003-2423-5800
Article History
Received: 10 July 2020
Accepted: 26 August 2020
First Online: 29 August 2020
Ethics approval and consent to participate
: This study was approved by the Comité de Ética de Investigación Clínica (CEIC) in Cantabria (internal code: 2013.267). Written informed consent was obtained from each patient included in the study.
: Not applicable.
: Dr. Hernandez reports research grants from Amgen, and fees for participation in company-sponsored speaker’s bureau from Amgen, MSD, and Bayer. Dr. R. Blanco received grants/research supports from Abbvie, MSD, and Roche, and had consultation fees/participation in company-sponsored speaker’s bureau from Abbvie, Pfizer, Roche, Bristol Myers, Janssen, and MSD. Dr. González-López had consultation fees/participation in company-sponsored speaker’s bureau from Abbvie. The rest of the authors declare that they have no competing interests.